Gender- and Age-Specific Associations of Visit-To-Visit Blood Pressure Variability with Incident Generalized Anxiety Disorder

Background: There is a bidirectional relationship between blood pressure variability (BPV) and generalized anxiety disorder (GAD), but few studies have examined the gender- and age-specific effects of visit-to-visit BPV on GAD incidence. We examined the predictive value of BPV for the incidence of GAD in a family clinic cohort. Methods: Consecutive patients with a first attendance to family medicine clinics in Hong Kong between January 1st, 2000, and December 31st, 2002, with at least three blood pressure measurements available thereafter were included. The primary endpoint was incident GAD as identified by ICD-9 coding from the local Clinical Data Analysis and Reporting System. Results: This study included 48023 (50% males) patients with a median follow-up of 224 (IQR: 217-229) months. Females were more likely to develop GAD compared to males (incidence rate: 7% vs. 2%), as were patients of older age. Significant univariate predictors were female gender, older age, pre-existing cardiovascular diseases, respiratory diseases, diabetes mellitus, hypertension, and gastrointestinal diseases, various laboratory examinations and the number of blood pressure measurements. Higher baseline, maximum, minimum, SD, CV, and variability score of diastolic blood pressure significantly predicted GAD, as did all systolic blood pressure measures (baseline, latest, maximum, minimum, mean, median, variance, SD, RMS, CV, variability score). Conclusions: The relationships between longer term visit-to-visit BPV and incident GAD were identified. Female and older patients with higher blood pressure and higher BPV were at the highest risks of GAD.


Introduction
Generalized anxiety disorder (GAD) is a common group of conditions characterized by excessive worry associated with fatigue, restlessness, muscle tension, irritability, sleeping difficulty, and concentration problems. It is a major public health problem in many countries, damaging not only psychological health, but also physical health and quality of life. There is a bidirectional relationship between blood pressure variability (BPV) and GAD. GAD can exert effects on BPV.
Patients with depressive symptoms presented a significantly lower night-time systolic BP fall than non-depressed patients after controlling for age, sex, and traditional cardiovascular risk factors (Scuteri et al., 2009). The control of negative emotions has been shown to influence BP control and BPV (Symonides et al., 2014). Conversely, increased beat-to-beat BPV has been associated with incident GAD (Virtanen et al., 2003). Longer term visit-to-visit BPV has also been reported as an independent predictor of cognitive impairment in several cohort studies (Nagai, Hoshide, Ishikawa, Shimada, & Kario, 2012;Sabayan et al., 2013;Yano et al., 2014). With the widespread measurement of BP measurements at home, fluctuations in blood pressure, as well as very high or low BP readings at home can cause anxiety in patients. However, few previous studies have examined the longitudinal relationship between BPV and anxiety disorders in older cohorts. In this study, we

Incidence of GAD on follow-up and significant predictors
The age-specific incidences of GAD among male and female subgroups are shown in Figure 1.
The number of female patients developing GAD was more than double that of male patients among those over 30 years of age. Kaplan-Meier survival curves in Figure 2 show that females had a higher risk of developing GAD than males.
Univariate Cox regression demonstrated the following significant predictors for incident GAD: In addition, the significant univariate predictors of all-cause mortality after GAD presentation were also identified ( Table 2). Significant univariate predictors (p<0.05) were entered into a multivariate Cox regression model, with most of the above univariate predictors remaining significant (Table 3). Next, we further analyzed different BP values in patients who developed GAD with age stratification (Figures 3 and 4; Supplementary Table 2). There is an age-related increase in mean, median and measures of variability for both diastolic and systolic BP.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 2, 2021. ;

Comparisons of BP measurements before and after GAD development
Gender-specific blood pressure measure changes before and after initial GAD presentation were identified as shown in Table 4

Discussion
The main findings of this study are that:

)
higher baseline, maximum, minimum, SD, CV, and variability score of diastolic BP significantly predicted GAD, as did all systolic BP measures (baseline, latest, maximum, minimum, mean, median, variance, SD, RMS, CV, variability score), . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 2, 2021. ; and 2) female and older patients with higher blood pressure and higher BPV were at the greatest risks of GAD.
The effects of GAD on BP and as a potential risk factor have been extensively examined in previous studies (Yu Pan et al., 2015). However, whether BP influences the risk of incident GAD has not been investigated in detail, and mixed results were seen in observational studies. Individuals with hypertension may be more likely to develop anxiety (Y. Pan et al., 2015;Player & Peterson, 2011), but this association is seen only when hypertension coexists with another chronic condition beat-to-beat BPV has been associated with incident GAD (Virtanen et al., 2003). Longer term visit-to-visit BPV has also been reported as an independent predictor of neurological conditions such as cognitive impairment in cohort studies (Nagai et al., 2012;Sabayan et al., 2013;Yano et al., 2014), but whether it can do so for incident GAD has never been explored. In this population-based study of patients attending family medicine clinics in the public sector of Hong Kong, we established for the first time the predictive value of different metrics of BP and BPV on incident GAD.
Whilst the physiological mechanisms underlying the bidirectional relationship between hypertension and incident GAD remain unclear, the phenomenon was reported in recent studies.
Population-based studies demonstrated that patients with baseline anxiety had an increased risk of essential hypertension. (Bacon, Campbell, Arsenault, & Lavoie, 2014;Perez-Pinar et al., 2016;Stein et al., 2014) By contrast, a territory-wide study of over two million patients in Sweden demonstrated that hypertensive patients were more likely to suffer from GAD. (Sandstrom, Ljunggren, Wandell, Wahlstrom, & Carlsson, 2016) The presence of anxiety increases the risk of poor drug compliance . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 2, 2021. ; amongst hypertensive patients, thus worsens their BP control. (Bautista, Vera-Cala, Colombo, & Smith, 2012) Various hypotheses have been proposed to explain the association between GAD and hypertension. First of all, chronic stress, which induces a persistent maladaptive stress response that develops into GAD, results in long term cortisol elevation. (Patriquin & Mathew, 2017) Consequently, the hypothalamic-pituitary-adrenal axis becomes dysregulated and leads to Similarly, hypotheses have been proposed to explain the predictive value of BPV for incident GAD. Increased BPV has been shown to be due to reduced baroreflex sensitivity, which may reflect sympathovagal imbalance likely due to sympathetic hyperactivity, which is observed in GAD patients. (Januzzi, Stern, Pasternak, & DeSanctis, 2000;Tully & Tzourio, 2017;Virtanen et al., 2003) The BP instability may reflect compensatory hemodynamic changes under reduced arterial compliance and increased aortic stiffness under systemic inflammatory response, which is both a cause of hypertension and a consequence of GAD. (Mitchell, 2009;Rothwell, 2010) Furthermore, the pathological worrying in GAD may be associated with increased compliance towards antihypertensives, which are known to increase BPV. (Parati, Ochoa, Lombardi, & Bilo, 2013; . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 2, 2021. ; Parker, Hyett, Hadzi-Pavlovic, Brotchie, & Walsh, 2011) Moreover, the use of medications such as beta blockers also predicted incident GAD. It may be that anxious patients may more likely to receive such medications to reduce the symptoms of anxiety.

Limitations
Several limitations should be noted for the present study. Given its observational nature, there is information bias with regards to issues of under-coding, missing data and documentation errors.
Moreover, data on lifestyle risk factors of hypertension, such as smoking and alcoholism, were unavailable, thus their potential influence on the relationship between BP and GAD cannot be assessed. Furthermore, the clinical circumstances of BP measurement during hospital visits were susceptible to the effects of circumstantial factors, which may introduce additional variables that affect patients' BP and BPV.

Conclusions
The relationships between longer term visit-to-visit BPV and incident GAD were identified.
Female and older patients with higher blood pressure and higher BPV were at the highest risks of GAD. Future studies should examine the interacting effects between BPV and medication use to influence incident GAD and GAD-related outcomes.

Acknowledgements
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 2, 2021. ; None.

Funding
None.

Competing or Conflicts of Interest
None.

Author Contributions
JZ, XW: data analysis, data interpretation, statistical analysis, manuscript drafting, critical revision of manuscript SL, WTW, WKKW, KSKL, TL: project planning, data acquisition, data interpretation, critical revision of manuscript BMYC: study supervision, data interpretation, statistical analysis, critical revision of manuscript QZ, GT: study conception, study supervision, project planning, data interpretation, statistical analysis, manuscript drafting, critical revision of manuscript . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 2, 2021.   is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 2, 2021. ; a n x i e t y a n  d  h  y  p  e  r  t  e  n  s  i  o  n  b  u  t  n  o  t  b  r  a  d  y  c  a  r  d  i  a  .  N  e  u  r  o  p  s  y  c  h  o  p  h  a  r  m  a  c  o  l  o  g  y  ,  3  7  (  8  ) , . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 2, 2021. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 2, 2021. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 2, 2021. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 2, 2021. ; is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 2, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 2, 2021.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 2, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 2, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 2, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 2, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 2, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 2, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 2, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 2, 2021.  Table 4. Gender-specific blood pressure measure changes before and after GAD development. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 2, 2021. ;